{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:03:55Z","timestamp":1793707435793,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jvir.2023.12.574","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T11:12:39Z","timestamp":1709118759000},"page":"1423-1434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mortality, Safety, and Effectiveness of Paclitaxel-Containing Balloons and Stents\u00a0in\u00a0the Femoropopliteal Artery: Systematic Review and Meta-Analysis of Randomized Controlled Trials since 2018"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-9426","authenticated-orcid":false,"given":"Hayley","family":"Briody","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor A.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4482-2255","authenticated-orcid":false,"given":"Michael J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2023.12.574_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Dua","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvir.2023.12.574_bib3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Zilver PTX Investigators. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2023.12.574_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1583\/13-4242.1","article-title":"Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis","volume":"20","author":"Indes","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvir.2023.12.574_bib5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib6","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2023.12.574_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions: five-year outcomes from the IN.PACT SFA randomized trial","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib8","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvir.2023.12.574_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/eci.12407","article-title":"Local delivery of paclitaxel in the treatment of peripheral arterial disease","volume":"45","author":"Ng","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jvir.2023.12.574_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvs.2014.01.041","article-title":"Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery","volume":"59","author":"Katsanos","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2023.12.574_bib11","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.ijcard.2013.06.081","article-title":"Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison","volume":"168","author":"Fusaro","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib12","first-page":"CD011319","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","volume":"2016","author":"Kayssi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvir.2023.12.574_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","article-title":"Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial","volume":"74","author":"Xu","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2023.12.574_bib14","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00270-022-03265-1","article-title":"Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty: 5-year results of the randomized controlled EffPac trial","volume":"45","author":"Teichgr\u00e4ber","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(23)02189-X","article-title":"Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis","volume":"402","author":"Parikh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2023.12.574_bib17","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jvir.2023.12.574_bib18","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.jcin.2018.07.041","article-title":"Drug-coated balloon angioplasty compared with uncoated balloons in the treatment of 200 Chinese patients with severe femoropopliteal lesions: 24-month results of AcoArt I","volume":"11","author":"Xu","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib19","doi-asserted-by":"crossref","first-page":"e1633","DOI":"10.4244\/EIJ-D-19-00292","article-title":"Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial","volume":"15","author":"Teichgr\u00e4ber","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jvir.2023.12.574_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1148\/radiol.2020191619","article-title":"Drug-coated balloon angioplasty of femoropopliteal lesions maintained superior efficacy over conventional balloon: 2-year results of the randomized EffPac trial","volume":"295","author":"Teichgr\u00e4ber","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2023.12.574_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/radiol.212622","article-title":"Femoropopliteal drug-coated balloon angioplasty: long-term results of the randomized EffPac trial","volume":"304","author":"Teichgr\u00e4ber","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2023.12.574_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"IN.PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2023.12.574_bib23","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"IN.PACT SFA Trial Investigators. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"IN.PACT SFA Trial Investigators. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/15266028211068769","article-title":"No mortality signal with Stellarex low-dose paclitaxel DCB: ILLUMENATE pivotal 4-year outcomes","volume":"29","author":"Lyden","year":"2022","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvir.2023.12.574_bib26","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.jcin.2018.07.029","article-title":"Clinical randomized trial evaluating novel, microcrystalline, and biocompatible polymer paclitaxel-coated balloon for the treatment of femoropopliteal occlusive disease: the BIOPAC trial","volume":"11","author":"Buszman","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1358863X20988360","article-title":"Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: three-year outcomes of the randomized BIOPAC trial","volume":"26","author":"Nowakowski","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvir.2023.12.574_bib28","first-page":"2221","article-title":"Assessment of mortality and factors affecting outcome of use of paclitaxel-coated stents and bare metal stents in femoropopliteal pad","volume":"9","author":"Falkowski","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jvir.2023.12.574_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","volume":"25","author":"Iida","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvir.2023.12.574_bib30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ccd.28048","volume":"93","author":"Iida","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvir.2023.12.574_bib32","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00270-018-1940-1","article-title":"Two-year clinical outcomes of the CONSEQUENT trial: can femoropopliteal lesions be treated with sustainable clinical results that are economically sound?","volume":"41","author":"Albrecht","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00270-017-1713-2","article-title":"Angiographic and clinical outcomes after treatment of femoro-popliteal lesions with a novel paclitaxel-matrix-coated balloon catheter","volume":"40","author":"Tepe","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcin.2019.12.028","article-title":"A\u00a0polymer-free paclitaxel-eluting stent versus a bare-metal stent for de novo femoropopliteal lesions: the BATTLE trial","volume":"13","author":"Gou\u00ebffic","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib35","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2023.12.574_bib36","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/1526602817725062","article-title":"Short-term results of the RAPID randomized trial of the Legflow paclitaxel-eluting balloon with Supera stenting vs Supera stenting alone for the treatment of intermediate and long superficial femoral artery lesions","volume":"24","author":"de Boer","year":"2017","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvir.2023.12.574_bib38","first-page":"679","article-title":"RAPID trial investigators. Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID trial","volume":"60","author":"de Boer","year":"2019","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jvir.2023.12.574_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2020.10.060","article-title":"Reewarm\u2122 PTX drug-coated balloon in the treatment of femoropopliteal artery disease: a multi-center, randomized controlled trial in China","volume":"326","author":"Ye","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006564","article-title":"DEBATE in SFA Investigators. Drug-eluting versus bare-metal stent implantation with or without cilostazol in the treatment of the superficial femoral artery","volume":"11","author":"Miura","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib41","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"EMINENT Investigators. Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2023.12.574_bib42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00270-019-02309-3","article-title":"The Randomized Freeway Stent Study: drug-eluting balloons outperform standard balloon angioplasty for postdilatation of nitinol stents in the SFA and PI segment","volume":"42","author":"Tacke","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcin.2018.01.276","article-title":"RANGER SFA Investigators. 12-month results from the first-in-human randomized study of the Ranger paclitaxel-coated balloon for femoropopliteal treatment","volume":"11","author":"Steiner","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"RANGER II SFA Investigators. 1-year results from the RANGER II SFA randomized trial of the Ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/17085381211013968","article-title":"Orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of femoropopliteal artery disease: 12-month result of the randomized controlled trial","volume":"30","author":"Liao","year":"2022","journal-title":"Vascular"},{"key":"10.1016\/j.jvir.2023.12.574_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.821672","article-title":"A\u00a0multicenter randomized trial assessing ZENFlow carrier-free drug-coated balloon for the treatment of femoropopliteal artery lesions","volume":"9","author":"Ni","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jvir.2023.12.574_bib47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/15266028211023505","article-title":"Mortality rates after paclitaxel-coated device use in patients with occlusive femoropopliteal disease: an updated systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Dinh","year":"2021","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvir.2023.12.574_bib48","article-title":"Safety of paclitaxel-coated devices in the femoropopliteal arteries: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2023.12.574_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ccd.28176","article-title":"Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: an updated meta-analysis of randomized controlled trials","volume":"94","author":"Anantha-Narayanan","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacc.2022.10.016","article-title":"Comparison of drug-coated balloons vs bare-metal stents in patients with femoropopliteal arterial disease","volume":"81","author":"Shishehbor","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib51","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jvs.2014.03.291","article-title":"Paclitaxel-coated balloons and aneurysm formation in peripheral vessels","volume":"62","author":"Diamantopoulos","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2023.12.574_bib52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jcin.2018.03.046","article-title":"1-year all-comers analysis of the Eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty","volume":"11","author":"Bisdas","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s42155-021-00245-3","article-title":"Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern","volume":"4","author":"Tsujimura","year":"2021","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.jvir.2023.12.574_bib54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaccas.2021.01.028","article-title":"Aneurysmal dilatation of the superficial femoral artery after endovascular intervention","volume":"3","author":"Avadhani","year":"2021","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.jvir.2023.12.574_bib55","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00270-019-02194-w","article-title":"Two-year mortality after angioplasty of the femoro-popliteal artery with uncoated balloons and paclitaxel-coated balloons-a pooled analysis of four randomized controlled multicenter trials","volume":"42","author":"Albrecht","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2023.12.574_bib56","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/ccd.29152","article-title":"Paclitaxel exposure: long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials","volume":"96","author":"Schneider","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.carrev.2021.04.010","article-title":"A\u00a0patient-level, pooled analysis of mortality rates with the Passeo-18 Lux paclitaxel drug-coated balloon in peripheral arterial disease","volume":"33","author":"Forrestal","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jvir.2023.12.574_bib58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.119.040518","article-title":"Mortality assessment of paclitaxel-coated balloons: patient-level meta-analysis of the ILLUMENATE clinical program at 3 years","volume":"140","author":"Gray","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2023.12.574_bib59","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.jcin.2019.08.025","article-title":"Safety of paclitaxel-coated balloon angioplasty for femoropopliteal peripheral artery disease","volume":"12","author":"Ouriel","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2023.12.574_bib60","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:56:55Z","timestamp":1727121415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1051044324001982"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2023.12.574","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality, Safety, and Effectiveness of Paclitaxel-Containing Balloons and Stents\u00a0in\u00a0the Femoropopliteal Artery: Systematic Review and Meta-Analysis of Randomized Controlled Trials since 2018","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2023.12.574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2024","name":"copyright","label":"Copyright"}]}}